MYRIAD GENETICS, INC. (MYGN) Net income 2016–2025
MYRIAD GENETICS, INC. (MYGN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$365.9MFY2025 · since FY2016: $17.4M → -$365.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$365.9M | -187.4% |
| FY2024 | -$127.3M | +51.7% |
| FY2023 | -$263.3M | -135.1% |
| FY2022 | -$112.0M | -311.8% |
| FY2021 | -$27.2M | +87.8% |
| FY2020 | -$223.6M | -12.1% |
| FY2019 | -$199.5M | -4437.0% |
| FY2018 | $4.6M | -96.5% |
| FY2017 | $133.3M | +666.1% |
| FY2016 | $17.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MYGN financial trends
MYGN RevenueMYGN Net marginMYGN Gross profitMYGN Gross marginMYGN Operating incomeMYGN Operating marginMYGN Operating cash flowMYGN Free cash flowMYGN Capital expendituresMYGN Return on equityMYGN Stock buybacksMYGN Dividends paidMYGN Total assetsMYGN Total liabilitiesMYGN Shareholders’ equityMYGN overview →